Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,014 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Recruiting

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

NCT07109219

Conditions
B-cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Iowa City, Iowa, United States
View all 26 locations
View Trial Details
Recruiting

Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia

NCT05327894

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Hospital de Pediatría S.A.M.I.C. "Juan P. Garrahan" Buenos Aires, Argentina
  • Australian and New Zealand Children's Haematology/Oncology Group Clayton, Victoria, Australia
  • North Adelaide- Womens and Childrens Hospital Adelaide, Australia
  • Monash Children's Hosptial Clayton, Australia
View all 124 locations
View Trial Details
Recruiting

CAR-T Cell Therapy for ALL

NCT07695012

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • National University of Medical Sciences, Clinical Trial Unit Rawalpindi, Pakistan
View Trial Details
Recruiting

A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

NCT05748171

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Cliniques universitaires Saint-Luc Brussels, Bruxelles-capitale, Région de, Belgium
  • UZ Gent Ghent, Oost-vlaanderen, Belgium
  • UZ Leuven Leuven, Vlaams-brabant, Belgium
View all 68 locations
View Trial Details
Recruiting

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

NCT07509151

Conditions
Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Research Site Adelaide, Australia
  • Research Site Fitzroy, Australia
  • Research Site Heidelberg, Australia
  • Research Site Nedlands, Australia
View all 30 locations
View Trial Details
Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

NCT04588922

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations
  • O'Neal Comprehensive Cancer Center, University of Alabama Birmingham, Alabama, United States
  • City of Hope - Phoenix Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 26 locations
View Trial Details

Related conditions